Chemoprevention of Post-ERCP Pancreatitis with Rectal NSAIDs: Does Poking Both Ends Justify the Means?

Dig Dis Sci. 2015 Oct;60(10):2863-4. doi: 10.1007/s10620-015-3746-1. Epub 2015 Jun 23.

Authors

Tilak Shah¹, Alvin Zfass², Mitchell L Schubert²

Affiliations

¹ Division of Gastroenterology, 111N, Hunter Holmes McGuire Veterans Affairs Medical Center and Virginia Commonwealth University Health System, 1201 Broad Rock Blvd, Richmond, VA, 23224, USA. Tilak.Shah@va.gov.
² Division of Gastroenterology, 111N, Hunter Holmes McGuire Veterans Affairs Medical Center and Virginia Commonwealth University Health System, 1201 Broad Rock Blvd, Richmond, VA, 23224, USA.

PMID: 26100145
DOI: 10.1007/s10620-015-3746-1

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
Diclofenac / administration & dosage*
Female
Humans
Male
Pancreatitis / prevention & control*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Diclofenac